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ABSTRACT
Cellular DNA is under constant attack from numer-
ous exogenous and endogenous agents. The
resulting DNA lesions, if not repaired timely,
could stall DNA replication, leading to genome
instability. To better understand the mechanism of
DNA lesion replication at the biochemical level,
we have attempted to reconstitute this process
in Xenopus egg extracts, the only eukaryotic
in vitro system that relies solely on cellular proteins
for DNA replication. By using a plasmid DNA
that carries a site-specific apurinic/apyrimidinic
(AP) lesion as template, we have found that DNA
replication is stalled one nucleotide before the
lesion. The stalling is temporary and the lesion is
eventually replicated by both an error-prone
mechanism and an error-free mechanism. This is
the first biochemical system that recapitulates
efficiently and faithfully all major aspects of DNA
lesion replication. It has provided the first direct
evidence for the existence of an error-free lesion
replication mechanism and also demonstrated that
the error-prone mechanism is a major contributor to
lesion replication.
INTRODUCTION
DNA replication is a remarkably accurate process.
For a genome like that in a human cell, every one of the
6 10
9nt is replicated once per cell cycle with extremely
high ﬁdelity. Moreover, this is achieved on a DNA
template that is far from ideal. Cellular DNA is under
constant attack from numerous environmental and
endogenous agents. While most of the lesions are rapidly
repaired, inevitably some are missed and pose as road-
blocks for the replication machinery. A major advance in
recent years is the recognition that lesion replication is of
utmost importance to genome maintenance and requires
the concerted action of a myriad of proteins involved
in replication, repair, recombination and checkpoint
response (1–4). However, the mechanism by which these
proteins work together to accomplish lesion replication is
still poorly understood, largely due to the lack of an
in vitro biochemical system that can recapitulate eﬃciently
and faithfully this intricate process. For example, two
general mechanisms of lesion replication have been
proposed, an error-prone mechanism by the action of
low-ﬁdelity translesion DNA polymerases and an error-
free mechanism by copying the missing information from
the sister chromatid. While there is compelling evidence
for the error-prone mechanism, it appears to represent
only a minor pathway when compared to homologous
recombination in Escherichia coli (5). To what extent
error-prone replication contributes to overall lesion
replication in eukaryotes remains to be determined.
As to the error-free mechanism, the experimental evidence
for its existence is still indirect (6). Further complicating
the issue is that correct nucleotides can also be inserted
opposite many types of lesions by the appropriate
translesion DNA polymerases, making it diﬃcult to
determine if a true error-free mechanism is involved in
replicating a lesion (7).
To rigorously study the mechanism of lesion replica-
tion, we have endeavored to reconstitute lesion replication
in the Xenopus egg extract. In this extract, DNA, usually
sperm chromatin, induces nuclear formation around itself
and the DNA within the nucleus is replicated once (8,9).
A more recent development is to use the nucleoplasmic
extract (NPE) derived from the nuclei reconstituted in the
crude egg extract to induce plasmid DNA replication
(10,11). The Xenopus system is the only system that relies
solely on cellular proteins such as ORC and MCMs for
replication, recapturing faithfully the complexity and
control of eukaryotic replication forks (12). This is in
sharp contrast to the much simpler replication fork
complex built around the large T antigen of the SV40
viral replication system that has previously been used for
lesion replication (13). In this study, we present evidence
to show that a site-speciﬁc lesion stalls DNA replication
one nucleotide before the lesion in the Xenopus system.
The stalling is transient and the lesion is eventually
replicated by both the error-prone and the error-free
mechanisms.
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Extract preparation
Crude interphase Xenopus egg extracts, membrane-free
cytosol, and NPE were prepared following the published
procedures (10,14).
AP-containing DNA preparation
The parental plasmid, pBS-Trx, was constructed by
inserting an NdeI fragment encoding the trxA gene
of pET-32a (Novagene) into the NdeI site of pBS-
(Stratagene). pBS-Trx DNAs containing a synthetic AP
site were constructed as previously described (15). Three
oligonucleotides, CCGGGTACC AGCTCG, CCGGGT
AC GAGCTCG and CCGGGT CCGAGCTCG were
designed to place the AP site opposite C, G or T
(‘ ’ denotes the synthetic AP site).
Dominant negativeAPE mutantprotein preparation
The dominant negative human APE1 mutant (E96Q/
D210N) was kindly provided by D. Wilson. The gene was
subcloned into pET32 vector to add a (His)6 aﬃnity tag at
the N terminus. The fusion protein was expressed in BL21
(Rosetta(DE3)) and puriﬁed on a Ni column followed by a
HiTrap Q column. The cell extract was loaded onto the
column at 15mM imidazole and the column was then
washed with buﬀer containing 70mM imidazole. dnAPE
was eluted with 100mM imidazole, re-loaded onto a Q
column, and eluted with buﬀer containing NaCl. The peak
fractions containing dnAPE was dialyzed against ELB
and concentrated with Aimcon Ultra-4 to 5mg/ml.
Replication assay
For a typical replication reaction, 0.25ml DNA (300ng/ml)
was pre-incubated with 1ml dnAPE (5mg/ml) and 2.25ml
ELB buﬀer (10mM HEPES (pH 7.5), 250mM sucrose,
2.5mM Mg2Cl, 50mM KCl and 1mM DTT) at room
temperature for 15min. After addition of 1ml cytosol and
0.5ml1 0   ATP cocktail (20mM ATP, 200mM phospho-
creatine and 0.5mg/ml creative kinase), the reaction was
incubated for another 45min. Finally, 10ml NPE, 2ml
dnAPE, 2ml1 0   ATP cocktail, 1ml
32P dATP and 5ml
ELB were added to accomplish DNA replication. Samples
taken at diﬀerent times were mixed with equal volume
of 2  sample (buﬀer 80mM Tris–HCl (pH 8), 0.13%
phosphoric acid, 8mM EDTA, 5% SDS, 0.2% bromo-
phenol blue and 10% Ficoll). The volume was brought up
to 10ml with 1  sample buﬀer and then 1ml proteinase K
(10mg/ml) was added. After overnight incubation at
room temperature, samples were separated on a 1% TAE/
agarose gel.
Analysis ofreplication products
DNA was isolated from an agarose gel and puriﬁed by
Qiagen gel extration columns. pET28a DNA (1mg total)
was used as a carrier DNA during puriﬁcation. For restric-
tion enzyme digestion analysis of the relaxed and super-
coiled replication products, the gel-puriﬁed DNA (20min
time point) was digested with various restriction enzymes
and then separated on a 1% agarose gel. The gel was ﬁrst
stained by SYBR Gold and then dried for
32P exposure.
For determination of the stalling site, the relaxed product
(20min time point) was ﬁrst tailed with either dCTP or
TTP using terminal deoxytransferase (TdT). PCR was then
performed with (dG)18 or (dA)18 and an upstream primer
(50 CCGTGTCAAAACTGTCGTC 30) using Taq DNA
polymerase. The products were cloned into pUC19 and
introduced into E. coli (DH5a) by transformation. The
plasmids were isolated from the colonies and the inserts
were sequenced. For analysis of the ﬁnal replication
products (after 75min of incubation in NPE), the puriﬁed
32P-labeled supercoiled DNA was subject to restriction
digestion by ClaI or DpnI or both. Half of the DNA was
analyzed by TAE agarose gel electrophoresis and the
remaining DNA was introduced into Maxi Eﬃciency
DH5a (Invitrogen, CA, USA) by transformation. The
plasmids from the transformants were isolated and the AP
lesion region was sequenced to determine the nucleotides
inserted opposite AP. Data from two independent experi-
ments were used to calculate the average ratio (and
absolute deviation) of each nucleotide inserted opposite
the AP lesion after replication. For the determination of
nucleotides on replicated DNA that still carried the AP
lesion, the DNA (after 75min of incubation in NPE) was
digested with DpnI, ClaI and APE (NEB, MA, USA),
puriﬁed by Qiagen column, and re-digested with KpnI.
This DNA was then used as template for PCR with two
primers (50 AGCGAGG AAGCGGAAGAGC 30 and 50
TGGTTGCCGCCACT TCACC 30) that bracket the ClaI
and KpnI sites. The PCR product was digested with NdeI
and SapI and then subcloned into pUC19 and introduced
into DH5a. The DNA was isolated from the transformants
and analyzed by restriction enzyme digestion and
sequencing.
APlesion protection assay
Two reactions, each containing 1mlo f :C DNA
(300ng/ml), were pre-incubated with 13ml dnAPE (4ml
protein(5mg/ml)and9mlELBbuﬀer)or13mlELBbuﬀerat
room temperature for 15min. After addition of 4ml cytosol
and2ml10 ATPcocktail,thereactionswereincubatedfor
another 65min. The DNA was puriﬁed by Qiagen PCR
puriﬁcation columns and treated with PstI, EarI and wild-
type AP endonuclease or buﬀer. The 30 EarI recessed ends
were then ﬁlled in with
32P TTP by Klenow and the DNA
were separated on a 5% urea polyacrylamide gel.
Determination of theeffect ofhemi-methylation
on ClaIsensitivity
The two strands surrounding the ClaI site in the parental
plasmid pBS-Trx were prepared by extending primers
corresponding to nucleotides 2495–2514 (50 CTGAGAGT
GCACCATATGGC 30; for copying the AP-carrying
strand) or 2849–2870 (50 GTATTTCACACCGCATATG
AGC 30; for copying the lesion-free strand) with
Sequenase in the presence of
32P-dATP, dGTP, dCTP
and TTP. The products were digested with NdeI to
generate the 345bp fragments that contained the hemi-
methylated ClaI site. The two NdeI fragments were then
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10% polyacrylamide gel and detected by exposure to
X-ray ﬁlm.
RESULTS
Asite-specific DNA lesion causes atransient stalling
ofDNA replication
To reconstitute DNA lesion replication, we replicated
a plasmid DNA that carried a site-speciﬁc lesion in NPE
(Figure 1A). The lesion chosen is an apurinic/apyrimidinic
(AP) site, which is abundant (16) and known to stall many
puriﬁed DNA polymerases (17). It is non-instructive, so
error-free and error-prone replication products can be
unambiguously distinguished. Normally, the AP lesion is
rapidly repaired in cytosol, prior to the initiation of
replication (Figure 1B). Even depletion of AP endonu-
clease I (xAPE I) failed to provide signiﬁcant protection of
the AP lesion, most likely due to the presence of another
AP endonuclease and/or other base repair pathways in the
extract (data not shown). We thus protected the AP lesion
with a dominant negative mutant of the human AP
endonuclease I (dnAPE) that cannot cleave but still binds
tightly to it (18). When dnAPE was included in the
reaction, the AP site was eﬃciently protected (>98% by
this assay) from repair (Figure 1B). As the AP endonu-
clease has no signiﬁcant aﬃnity for single-strand AP sites
[(18) and data not shown], the mutant protein would fall
oﬀ the unwound DNA and not by itself pose a hindrance
to DNA polymerases.
The AP DNA was replicated in NPE supplemented with
either dnAPE or buﬀer (for the replication reactions in
this study, dnAPE was included to protect the AP lesion
unless otherwise indicated). In the absence of dnAPE
(AP lesion repaired), the DNA was gradually replicated
and converted to supercoiled plasmids (Figure 1C). In the
presence of dnAPE (AP lesion protected), the supercoiled
replication product was still generated, but there was a
transient accumulation of the relaxed form. For example,
at the 200 time point, the supercoiled form and the relaxed
form were present at similar levels. By 60’, most of the
Figure 1. Establishment of the AP lesion replication system. (A) Experimental design for AP lesion replication. A plasmid DNA that carries a
synthetic AP site ( ) is ﬁrst incubated with the dominant negative human APE (dnAPE) to protect the AP lesion and then with cytosol to assemble
the pre-replication complex. Replication was initiated by the addition of NPE and monitored by
32P dATP. (B) Protection of AP containing DNA by
dnAPE. The presence of AP site was detected by digestion with restriction enzymes PstI and EarI plus or minus AP endonuclease (wtApe). The EarI
ends were then ﬁlled in with
32P TTP by Klenow and the DNA fragments were separated on a 5% urea polyacrylamide gel. (C) The replication of
the AP lesion-containing DNA.  :C plasmid was replicated in the presence of dnAPE (AP lesion protected) or buﬀer (AP lesion repaired). Samples
taken at the indicated times were de-proteinized with SDS and proteinase K and separated on a 1% TAE agarose gel and the gel was dried
for exposure to phosphoimager. R: relaxed; S: supercoiled; L: linear. (D) Eﬀect of dnAPE on the replication of the normal plasmid DNA pBS-Trx.
The DNA was replicated in the presence of dnAPE or buﬀer and analyzed in the same way as in (C).
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eﬀect was speciﬁc for the AP DNA as the non-AP DNA
was not aﬀected by dnAPE (Figure 1D). (The slight excess
of the relaxed products in the presence of dnAPE was
most likely due to the unavoidable basal level of random
AP lesions, formed either by spontaneous base loss or
as the intermediates of base excision repair of damaged
bases in the extract.)
These data suggested that the lesion-free strand was
replicated normally and gave rise to the supercoiled
product. The AP-carrying strand, in contrast, was
temporarily stalled and DNA synthesis restarted down-
stream, by either the same fork or the opposing fork,
forming a gap at or near the lesion (Figure 2A). To test
this hypothesis, we isolated the relaxed and supercoiled
products of the 20’ time point from the agarose gel and
digested the DNA with various restriction enzymes.
As shown in Figure 2B, the supercoiled product was
completely digested by all of the enzymes, but the relaxed
product was completely digested by only a subset of the
enzymes. Many of the enzymes could not digest well the
relaxed product even though they completely digested
pET28a plasmid, which was used as the carrier for DNA
puriﬁcation and served as the internal control for
restriction digestion. When the digestion pattern was
plotted on the plasmid, the enzymes that failed to digest
the relaxed product were found to have sites within a small
region immediately downstream of the AP site [with the
exception of ClaI (see subsequently)]. This observation
strongly suggested that most of the relaxed product
carried a gap between the EcoRI site immediately 50 to
the AP site and the PvuII site 257nt downstream of the
AP site.
The stalling occurs onthe lesion-carrying strand
The digestion by ClaI, which has a site 886nt upstream
of the lesion, did not conform to the above pattern.
While ClaI completely digested the supercoiled product,
it was very ineﬃcient in digesting the relaxed product
(Figure 2B). An examination of the sequence revealed that
this particular ClaI site overlaps with a GATC dam
methylation site and methylation is known to block ClaI
digestion. After one round of replication, the two
daughter molecules would be hemi-methylated, but at
diﬀerent adenines within the ClaI site (Figure 3A), and
might therefore be diﬀerentially digested by ClaI. To test
this hypothesis, we used a DNA polymerase to copy the
two strands of the NdeI fragment that contains the ClaI
site. The two hemi-methylated products were then
digested by ClaI. As shown in Figure 3B, the product
copied from the lesion-free strand was digested, but the
product from the lesion strand was not. This observation
showed that the supercoiled replication product (ClaI
sensitive) was exclusively derived from the lesion-free
strand (which also suggested that the AP site was not
repaired before replication). The gap, on the other hand,
was present on the replication product derived from the
AP strand (ClaI resistant).
The stalling occurs onenucleotide before the APsite
We next determined exactly where the AP lesion stalled
replication. The strategy was to ﬁrst add a tail (dC or dT)
to the 30 end of the stalled strand of the gel-puriﬁed
Figure 2. Restriction enzyme mapping of the replication intermediate.
(A) Probable products of the lesion-carrying strand and lesion-free
strand after replication. (B) The relaxed and supercoiled products of
the 20min time point were gel-puriﬁed, digested with the indicated
restriction enzymes and separated on 1% agarose gels. The gels were
stained with SYBR Gold to detect the control DNA pET28a and then
dried for exposure to Phosphoimager to detect the
32P signal of the
replication products. pET28a lacks a PstI site, but the enzyme caused
some nicking to the DNA. PvuII cuts  :C at 2 sites. HincII and
NgoM1V cut pET28a at 2 and 4 sites, respectively. (C) Plot of the
restriction digestion pattern of the relaxed product. (+): cut; ( ) uncut.
Figure 3. Eﬀect of ClaI hemi-methylation. (A) The predicted methy-
lation pattern of the ClaI site in  :C after one round of replication.
(B) ClaI digestion of the two hemi-methylated, ClaI-containing NdeI
fragments copied from  :C.
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cleotidetransferase (TdT) and then use a primer comple-
mentary to this tail and another primer further upstream
to amplify the intervening region (Figure 4A). The PCR
product was cloned into a vector and introduced into
E. coli by transformation. The plasmid DNA was isolated
from the transformants and the inserts were sequenced.
As shown in Figure 4B, most of the clones from the dT
tailing reaction (17/21) ended in GAGCT...T, and most
of the clones from the dC tailing reaction (20/26) ended
in GAGCTC...C. Combining the two sets of data,
it became clear that the major stalling site was one
nucleotide before the AP site, indicating that the replica-
tion of the lesion per se was kinetically slow. In addition,
this experiment and the one above provided further
evidence that replication stalling was caused by the
lesion rather than the steric hindrance of the dominant
negative mutant APE. A steric hindrance would be
extremely unlikely to stall just one template strand and
one nucleotide before the lesion.
Botherror-free and error-prone mechanisms are usedto
replicate theAP lesion
The replication stalling was only temporary and the AP
lesion was eventually replicated over, leading to the
accumulation of completely replicated, supercoiled pro-
duct. If the AP lesion was replicated by copying the
information from the lesion-free sister chromatid (error-
free mechanism), the correct nucleotide would be expected
at the position opposite the lesion. In contrast, if the AP
lesion was replicated by translesion DNA polymerases
(error-prone mechanism), then incorrect nucleotides
would be expected. Furthermore, depending on what
translesion polymerases were recruited, all 4nt might be
used at random or some nucleotides might be used in
preference. To distinguish among these possibilities, we
puriﬁed the ﬁnal supercoiled replication products (after
75min of replication in NPE) from an agarose gel. The
DNA was treated with DpnI (to digest any residual
unreplicated, fully methylated DNA; the plasmid contains
18 DpnI sites) and ClaI (to digest the product from the
lesion-free template strand) and then introduced into
E. coli by transformation. As a control, DpnI and ClaI
were found to have eﬃciently digested the pET28a carrier
DNA, as shown by both DNA agarose gel staining and
transformation assay (Figure 5A and B). The plasmids
were isolated from the transformants and sequenced.
(E. coli could accurately repair the AP lesion. In a control
experiment, 34 transformants from the AP DNA were
examined and all were found to be correctly repaired.)
In this experiment, among the 44  :C replication pro-
ducts sequenced, 28 had a C, 13 an A, 1a G and 1a T
inserted opposite the AP site. (Figure 5C, middle column).
A was an incorrect nucleotide, clearly the product of
error-prone lesion replication. C was the correct nucleo-
tide, suggesting that the AP lesion might also be replicated
by an error-free mechanism, but the error-prone mechan-
ism could not be ruled out because Rev1, a translesion
DNA polymerase, is known to insert a C opposite an
AP site (19). To resolve this uncertainty, we performed
a similar analysis on the replication products from a DNA
that carried an AP lesion opposite a G ( :G). If a true
error-free mechanism had been used, then more Gs (and
correspondingly fewer Cs) would now be found opposite
the AP site. This was indeed the case. In this experiment,
among the 39  :G replication products sequenced, 16 had
a G, 14 an A, 8a C and 1a T inserted opposite the AP site
(Figure 5C, right column). We repeated these experiments
and calculated the average ratios of each nucleotide
inserted opposite the AP site on  :C and  :G replication
products. As shown in Figure 5D, the ratios were very
diﬀerent between  :C and  :G replication products and
deviated dramatically from the expected ratios of random
insertion. Together, these data strongly suggested that
both an error-free mechanism (inserting C for  :C and G
for  :G) and an error-prone mechanism (inserting A and
C but rarely T and G for both substrates) were used to
replicate the AP lesion.
These data provided the ﬁrst biochemical evidence
for the existence of error-free lesion replication, but
a mundane explanation was that the correct nucleotide
was inserted on DNA whose AP lesion had been repaired
before replication. While this seemed very unlikely as AP
sites were eﬃciently protected, we nevertheless attempted
to determine if the correct nucleotide was inserted on  :G
replication products that still carried the AP lesion [95%
of the AP strand replication products still carried the AP
lesion (Supplementary Figure S2)]. The AP lesion in  :G
was embedded within a KpnI site, and the nicking of the
lesion by AP endonuclease rendered the DNA completely
resistant to KpnI digestion (Supplementary Figure S3A).
As illustrated in Figure 6A, we digested the puriﬁed
replication products with DpnI (to remove any
Figure 4. Determination of the stalling sites of DNA replication. (A)
Experimental strategy to clone the stalled intermediates. The arrows
illustrate the primers used for PCR. The templates for tailing and PCR
were the gel-puriﬁed relaxed DNA from the 20min time point. (B)
Sequencing data of the PCR products showing the position of stalling.
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lie between ClaI and KpnI), ClaI (to remove the product
of the lesion-free strand), APE (to nick the AP site) and
ﬁnally KpnI (to remove all DNA with an intact KpnI site,
including the putative pre-repaired DNA and their
replication products). The digested DNA was then used
as the template for PCR with two primers that bracketed
the ClaI and KpnI sites. The correct nucleotide could only
be recovered on PCR products ampliﬁed from the newly
replicated strand of the DNA that still carried the AP
lesion. As a control for digestion eﬃciency, the DNA
puriﬁed from a replication reaction containing the normal
plasmid pBS-Trx (used in AP DNA construction) did
not generate any PCR product after digestion with all four
enzymes (Supplementary Figure S3B). In contrast, the
DNA puriﬁed from the  :G replication reaction gener-
ated the expected PCR product even after digestion with
all four enzymes. This PCR product was subcloned into
pUC19 and the DNA isolated from the transformants was
analyzed by sequencing. As shown in Figure 6B, 17 out 50
had the correct nucleotide G, and the remaining clones
had mostly A and C but rarely T. In contrast, when the
 :T DNA was used as the substrate, T was now
frequently found opposite the AP lesion, but G became
rare (Figure 6C). Together, the results from these and the
above experiments demonstrated that both error-prone
and error-free mechanisms were used to replicate the
AP lesion.
DISCUSSION
In this study, we have shown that a site-speciﬁc AP lesion
causes a strong stalling to DNA replication in an in vitro
system that faithfully and eﬃciently recapitulates eukary-
otic DNA replication. The stalling occurs only on the
lesion-carrying template strand but not the lesion-free
template strand. The major stalling site is one nucleotide
before the lesion and the replication fork complex is slow
in ﬁlling the position directly opposite the lesion. New
DNA synthesis is initiated downstream of the lesion,
either by the same fork or by the opposing fork, leading to
the formation of a gap immediately downstream of the
Figure 5. Determination of the nucleotides opposite the AP site in the ﬁnal replication products (after 75min of incubation in NPE). (A) Restriction
digestion of the gel-puriﬁed supercoiled ﬁnal replication products (detected by
32P) and the control pET28a DNA (detected by SYBR Gold). R:
relaxed; L: linear; S: supercoiled. (B) Transformation eﬃciency of pET28a (kan
R; expressed in percentages of the number of transformants of the
uncut DNA) and AP DNA (amp
R; expressed in absolute colony numbers). (C) The nucleotides found at the position opposite the AP lesion in the
plasmids isolated from the transformants of the DpnI and ClaI-digested  :C and  :G replication products. (D) The average ratios and absolute
deviations of each nucleotide inserted at the position opposite the AP lesion for the  :C and  :G replication products. The data were from two
independent experiments for each substrate. The right-most column listed the expected ratios if the AP lesion was replicated by random insertion
of the 4nt.
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eventually replicated over. Most importantly, both error-
prone and error-free mechanisms are used to replicate the
AP lesion. Previous studies that use SV40 viral replication
system or puriﬁed E. coli replication proteins have
partially reconstituted some aspects of lesion replication
such as fork stalling and translesion synthesis (20–25). The
system established in this study is the ﬁrst to reconstitute
with high eﬃciency all major aspects of lesion replication
and has provided some important insights into the
mechanism of eukaryotic lesion replication.
The AP lesion is the only type of DNA lesions that
allows a deﬁnitive distinction between error-free products
and error-prone products. The drawback is that it is
extremely eﬃciently repaired in Xenopus extracts and has
to be protected. The only way we have found to eﬀectively
protect the AP lesion is by the addition of a dominant
negative AP endonuclease mutant. An obvious concern is
that this strategy might introduce an artifact that the
mutant protein itself causes replication stalling. Several
observations argue against this possibility. The stalling
occurs only on the lesion-carrying template strand but not
on the lesion-free strand. As such, the mutant protein does
not bind to the AP lesion so tightly that it blocks DNA
unwinding. The major stalling site is one nucleotide before
the position opposing the AP lesion. This precise position
also strongly suggests that the AP lesion rather than steric
hindrance from the mutant protein is the cause of stalling.
Consistent with this interpretation, many replicative
DNA polymerases, including DNA polymerase d, stall
at one nucleotide before the lesion (7). In addition, the
AP endonuclease is known to have very low aﬃnity for
the lesion on single-stranded DNA. Collectively, these
observations strongly suggest that the strategy used in this
study does recapitulate DNA lesion replication.
The error-free mechanism by copying the correct
information from the sister chromatid is often invoked
as a major pathway for lesion replication, but direct
evidence has so far been lacking. In fact, in addition to the
error-free mechanism, translesion DNA polymerases
can also insert the correct nucleotides opposite certain
lesions such as thymine dimers and thymine glycol (7).
For example, the XP-V gene product was once thought
to participate in error-free replication but later shown
to insert 2 As opposite a thymine dimer via its translesion
polymerization activity (26,27). AP sites are non-
instructional, so the error-free products generated in our
in vitro system have to somehow copy the correct
information from the sister chromatid. This study thus
provides the ﬁrst direct evidence for an error-free
mechanism of lesion replication. The correct information
might be copied by either replication fork regression or
homologous recombination. Future studies with the
Xenopus lesion replication system should help reveal the
molecular details of error-free lesion replication.
Our data also indicate that the error-prone mechanism
can make a signiﬁcant contribution to lesion DNA
replication and that A and C are the major nucleotides
inserted opposite an AP lesion. Previous studies in yeast
have produced various results ranging from randomly
inserted nucleotides (28) to A (29,30), C (31), G (32) or
T (33) as the main nucleotide inserted opposite AP
sites. However, these studies were not designed to directly
examine the replication of a deﬁned AP site by a
replication fork complex. Our data show that both the
‘A rule’ and the ‘C rule’ are used in the translesion
replication of AP sites in eukaryotes. This conclusion is
supported by the enzymatic activities of DNA polymerase
Pold and Rev1, which are respectively capable of inserting
A and C opposite of an AP site, and by genetic analysis
showing that Pold and Rev1 are important for MMS-
induced (via AP intermediates) mutagenesis in yeast
(7,30). Future studies using the system described here
should help reveal what roles the various DNA poly-
merases play in translesion replication and how the error-
free and error-prone mechanisms are controlled.
Figure 6. Analysis of the replication products that still carried the AP
lesion (after 75min of incubation in NPE). (A) Six potential types of
DNA and their sensitivity to various enzymes. The lesion-carrying
DNA would be nicked on the AP strand but intact on the
complementary strand. BER: base excision repair; H: non-G; D:
non-C. (B) Sequence analysis of the cloned PCR products ampliﬁed
from  :G replication products that had been digested with DpnI, ClaI,
APE and KpnI. (C) Sequence analysis of the cloned PCR products
ampliﬁed from  :T replication products that had been digested with
DpnI, ClaI, APE and KpnI.
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